|
|
|
| Effect of Bupi Yishen Huoxue Decoction on patients with renal anemia in the TCM symptom type of deficiency of spleen and kidney and blood stasis |
| ZHANG Rongdong1 LIN Yinghua1 LIN Ying2 |
1.Department of Chinese Medicine, Ningde City Hospital Affiliated of Fujian Medical University, Fujian Province, Ningde 352100, China;
2.Department of Haematology and Rheumatology, Ningde City Hospital Affiliated of Fujian Medical University, Fujian Province, Ningde 352100, China |
|
|
|
Abstract Objective To observe the effect of Bupi Yishen Huoxue Decoction on patients with renal anemia in the TCM symptom type of deficiency of spleen and kidney and blood stasis. Methods Sixty cases with renal anemia admitted to Department of Chinese Medicine, Ningde City Hospital Affiliated of FuJian Medical University from May 2017 to March 2018 were selected and they were divided into treatment group and control group, with 30 cases in each group by random number table method. The control group was given basic treatment, and the treatment group was given the Bupi Yishen Huoxue Decoction based on the treatment in the control group. The two groups were treated for 2 months. Clinical syndrome score, red blood cell (RBC), Haemoglobin (Hb), hematocrit value (HCT), blood urea nitrogen (BUN) and serum creatinine (Scr) were observed and compared between the two groups. Results After treatment, the clinical syndrome scores of the two groups were lower than those before treatment, and the differences were statistically significant (P ＜ 0.05), the score in the treatment group was lower than that in the control group (P ＜ 0.05). After treatment, RBC, Hb, HCT in the two groups were higher than those before treatment, the differences were significant (P ＜ 0.05), meanwhile the levels in the treatment group were higher than those in the control group (P ＜ 0.05). After treatment, BUN and Scr in the two groups all decreased compared to those before treatment (P ＜ 0.05), meanwhile the levels in the treatment group were lower than those in the control group (P ＜ 0.05). There were no obvious adverse reactions in the two groups. Conclusion Bupi Yishen Huoxue Decoction can effectively improve renal anemia and renal function, which is worth of promotion.
|
|
|
|
|
|
[1] Li Y，Shi H，Wang W，et al. Prevalence，awarenessand treatment of anemia in Chinese patients with nondialysischronic kidney disease [J]. Medicine，2016，95（24）：e3872.
[2] 林攀，丁小强，袁敏，等.慢性肾脏病患者贫血患病现况调查[J].复旦学报：医学版，2009，36（5）：562-565.
[3] He J，Shlipak M，Anderson A，et al. Risk factors for heart failure in patients with chronic kidney disease：the CRIC（chronic renal insufficiency cohort）study [J]. J Am Heart Assoc，2017，6（5）：e5336.
[4] Inker LA，Astor BC，Fox CH，et al. KDOQI US Commentary on the 2012 KDIGO Clinical Practice Guideline for the Evaluation and Management of CKD [J]. Am J Kidney Dis，2014，63（5）：713-735.
[5] 郑筱萸.中药新药临床研究指导原则（试行）[M].北京：中国医药科技出版社，2002：163-164.
[6] 余雯枫，余毅.肾性贫血的诊治进展[J].世界临床药物2018，39（3）：211-216，219.
[7] Happy C，Abraham RA，Himashree B，et al. Association of secondary hyperparathyroidism with hemoglobin level in patients with chronic kidney disease [J]. J Lab Physicians，2013，5（1）：51-54.
[8] Chen L，Ling Y，Lin C，et al. High dose ESAs are associated with high iPTH levels in hemodialysis patients with end-stage kidney disease：a retrospective analysis [J]. Front Public Health，2015，3：258-258.
[9] 周丽娜，王玉新.慢性肾脏病患者肾性贫血的药物治疗进展[J].世界临床药物，2016，37（4）：228-231.
[10] 窦涪琳，王杨威，崔文鹏，等.微炎症状态与肾性贫血[J].中国血液净化，2016，15（3）：145-148.
[11] 王莉君，袁伟杰.关于肾性贫血治疗相关指南与共识回顾[J].中国血液净化，2018，17（1）：1-5.
[12] 韩海燕，路建饶，王新华，等.叶景华治疗肾性贫血经验[J].中医杂志，2013，54（24）：2085-2087.
[13] 罗俊华，巴元明.邵朝弟治疗肾性贫血经验[J].中国中医药信息杂志，2015，22（1）：109-110.
[14] 赵霞.肾性贫血基本方[J].中国中西医结合肾病杂志，2001（11）：676.
[15] 曲晓璐，戴芹，唐咏华，等.黄芪注射液对血液透析患者氧化应激状态的影响[J].中国中西医结合肾病杂志，2008，9（1）：55-56.
[16] 宋锦叶，孟立强，李晓玫.黄芪与当归的现代药理学研究进展[J].中国中西医结合肾病杂志，2008，9（9）：833.
[17] 孙政华，邵晶，郭玫.黄芪化学成分及药理作用研究进展[J].中医临床研究，2015，7（25）：22-25.
[18] 谢志芬.慢性肾脏病肾性贫血的中西医结合治疗[J].实用中西医结合临床，2015，15（7）：42-43.
[19] 董晴，陈明苍.当归化学成分及药理作用研究进展[J].亚太传统医药，2016，12（2）：32-34.
[20] 卓丽红.（制）何首乌对血虚模型大鼠补血作用机制研究[D].广州：广州中医药大学，2012.
[21] 梅雪，余刘勤，陈小云，等.何首乌化学成分和药理作用的研究进展[J].药物评价研究，2016，39（1）：122-131. |
|
|
|
